目的:觀察持續(xù)腹腔引流治療頑固性腹水的療效。方法:將頑固性腹水患者74例分為兩組,治療組38例,采用腹腔置管,持續(xù)腹腔引流腹水,3000mL/天;對照組36例,以常規(guī)補(bǔ)充白蛋白、限鈉、限水、利尿治療為主,比較兩組的療效。觀察治療組治療前后患者尿量、腹圍和體重變化,并比較治療組與對照組在肝、腎功能及電解質(zhì)的變化及總體療效。結(jié)果:治療組療效優(yōu)于對照組(P lt;0.05),與治療前比較,治療組治療后尿量、腹圍、體重有明顯改變(P lt;0.01), 肝、腎功能及電解質(zhì)與對照組比較無明顯變化(P gt;0.05)。結(jié)論:持續(xù)腹腔引流治療頑固性腹水經(jīng)濟(jì)適用,不良反應(yīng)少,患者依從性好。
引用本文: 胡蓉,曾義嵐,王麗,唐玉珍,張瓊. 持續(xù)腹腔引流治療頑固性腹水38例的臨床觀察. 華西醫(yī)學(xué), 2009, 24(8): 2025-2026. doi: 復(fù)制
1. | 中華醫(yī)學(xué)會傳染病與寄生蟲病學(xué)分會、肝病學(xué)分會.病毒性肝炎防治方案[J].中華傳染病雜志,2001,19:56-62. |
2. | RUNYON B A. Practice Guidelines Cominitlee, American Association for the study of liver Diseases (AASLD).Management of adult Patients With ascites due to cirrhosis[J]. Hepatology,2004,39(3):841-856. |
3. | MOORE K P, AITHAL G P. Guidelines on the management of ascites in cirrhosis[J].Gut, 2006,55 Suppl 6:1-12. |
4. | 姚希賢.肝硬化頑固性腹水的研究現(xiàn)狀與進(jìn)展[J].現(xiàn)代消化及介入診療,2005,10(2):87-88. |
5. | 田冀虹,譚萬初,周道慧.肝硬化難治性腹水的臨床治療研究進(jìn)展[J]. 實(shí)用中醫(yī)內(nèi)科雜志,2006,20(4):359-360. |
- 1. 中華醫(yī)學(xué)會傳染病與寄生蟲病學(xué)分會、肝病學(xué)分會.病毒性肝炎防治方案[J].中華傳染病雜志,2001,19:56-62.
- 2. RUNYON B A. Practice Guidelines Cominitlee, American Association for the study of liver Diseases (AASLD).Management of adult Patients With ascites due to cirrhosis[J]. Hepatology,2004,39(3):841-856.
- 3. MOORE K P, AITHAL G P. Guidelines on the management of ascites in cirrhosis[J].Gut, 2006,55 Suppl 6:1-12.
- 4. 姚希賢.肝硬化頑固性腹水的研究現(xiàn)狀與進(jìn)展[J].現(xiàn)代消化及介入診療,2005,10(2):87-88.
- 5. 田冀虹,譚萬初,周道慧.肝硬化難治性腹水的臨床治療研究進(jìn)展[J]. 實(shí)用中醫(yī)內(nèi)科雜志,2006,20(4):359-360.